首页> 外国专利> SOLID PHARMACEUTICAL FORMULATION CONTAINING RANITIDINE AND METHOD FOR PREPARING RANITIDINE-SUPPORTING PARTICLE

SOLID PHARMACEUTICAL FORMULATION CONTAINING RANITIDINE AND METHOD FOR PREPARING RANITIDINE-SUPPORTING PARTICLE

机译:包含雷尼替丁的固体药物制剂和制备雷尼替丁支持颗粒的方法

摘要

PROBLEM TO BE SOLVED: To provide a solid pharmaceutical formulation containing ranitidine that controls discoloration of the ranitidine, and a method for producing a ranitidine-supporting particle to be blended with the formulation.;SOLUTION: The solid pharmaceutical formulation containing ranitidine is characterized in that it has acid-controlling power larger than 200 mL which is determined by the acid-controlling power testing method according to the fifteenth Revision of Japanese Pharmacopoeia and that it contains the ranitidine-supporting particle which supports the ranitidine on an inorganic compound containing magnesium and/or calcium having a magnesium and/or calcium content of 20 mass% or higher.;COPYRIGHT: (C)2010,JPO&INPIT
机译:解决的问题:提供一种包含雷尼替丁的固体药物制剂,该固体药物制剂控制雷尼替丁的变色,以及制备与该制剂混合的雷尼替丁支撑颗粒的方法。解决方案:包含雷尼替丁的固体药物制剂的特征在于:它具有大于200 mL的酸控制能力,该酸控制能力是根据日本药典第15次修订版通过酸控制能力测试方法确定的,并且含有雷尼替丁支持颗粒,该颗粒可将雷尼替丁负载在含有镁和/的无机化合物上或镁和/或钙含量为20质量%或更高的钙。版权所有:(C)2010,JPO&INPIT

著录项

  • 公开/公告号JP2010168371A

    专利类型

  • 公开/公告日2010-08-05

    原文格式PDF

  • 申请/专利权人 LION CORP;

    申请/专利号JP20090292765

  • 发明设计人 OTANI AKI;ISHIKAWA SATOYUKI;

    申请日2009-12-24

  • 分类号A61K31/341;A61K9/20;A61K47/04;A61P43/00;A61P1/04;C07D307/52;

  • 国家 JP

  • 入库时间 2022-08-21 19:03:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号